A practical reference on Deamidation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-08-02. Anything still debated is marked as such rather than presented as settled.
Temperature is the most common controlled variable, but its effect is not linear. Lower temperatures reduce most chemical reaction rates, yet freezing can concentrate solutes and create pH shifts in the remaining liquid phase. Repeated freeze-thaw cycles can denature or aggregate some peptides, especially those with hydrophobic segments. For lyophilized powders, desiccation and protection from moisture are often more important than deep freezing. For solutions, the choice between refrigeration and freezing depends on peptide concentration, buffer components, and the intended duration of storage.
Peptides are short chains of amino acids whose physical and chemical stability depends on sequence, length, conformation, and the surrounding matrix. In the solid state, lyophilized powders are generally more stable than solutions because low water activity slows hydrolysis and oxidation. Residual moisture, oxygen, trace metals, and light can still promote degradation over time. Storage recommendations therefore balance temperature, humidity, and container integrity rather than relying on a single condition. The optimal condition for a given peptide is often determined empirically because no universal rule covers every sequence.
After reconstitution, solutions are divided into single-use aliquots and stored at -80°C. Labels include peptide name, concentration, buffer composition, date, and lot number. Freeze-thaw cycles are minimized by thawing only the needed aliquot on ice or at room temperature. Some peptides benefit from the addition of a carrier protein, such as bovine serum albumin, or a cryoprotectant like glycerol to reduce adsorption to plastic. Glass vials with low-binding surfaces are preferred for dilute solutions. Shipping of frozen aliquots uses dry ice and insulated containers to maintain the cold chain.
Receiving a peptide shipment requires immediate inspection of the packaging and temperature indicators. Any deviation from the specified cold chain should be documented and investigated. Upon arrival, solid peptides are generally kept at -20°C, whereas liquid formulations are stored at -80°C. Vials should be kept upright and protected from light. Repeated warming and cooling of the entire container is avoided by preparing smaller working aliquots. A log of lot numbers, receipt dates, and storage locations supports traceability and quality control.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid; may appear fluffy or crystalline |
| Solubility class | Water-soluble or sparingly soluble | Depends on sequence and counter-ion content |
| Typical storage temperature | -20 °C or lower for solids | Refrigeration may suffice for short-term use |
| Common analytical method | Reverse-phase HPLC | Purity and degradation products are often assessed by UV detection |
| Primary stability risks | Moisture, oxygen, light, heat | Aggregation and hydrolysis can also occur in solution |
Temperature is a primary factor because most degradation reactions proceed more slowly at lower temperatures. Lyophilized peptides are commonly held at -20 °C or below, although some sequences remain stable at 2–8 °C for limited periods. Moisture uptake during handling can accelerate hydrolysis, so sealed containers and desiccants are used. Solutions are generally less stable than powders and may require freezing at -80 °C or refrigeration, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation even when the storage temperature is otherwise suitable.
Light, oxygen, and pH influence peptide integrity through specific side-chain reactions. Methionine and cysteine residues are susceptible to oxidation, and tryptophan can degrade under strong light. Inert gas overlays and amber glass or opaque containers reduce these risks. pH affects charge, solubility, and the rate of deamidation or aggregation; a value that minimizes one pathway may increase another. The optimal pH and buffer for a given peptide are often determined experimentally, and open questions remain about predicting stability from sequence alone.
Peptides are short chains of amino acids linked by amide bonds, and their storage stability depends on sequence, length, and three-dimensional structure. Chemical degradation can occur through hydrolysis, oxidation, deamidation, and aggregation, while physical changes such as precipitation or surface adsorption reduce recovery. Storage conditions are chosen to slow these processes without altering the peptide itself. Because peptides vary widely, no single condition suits every sequence, so laboratories often establish stability empirically for each batch.
Handling begins before a peptide arrives at the bench. Containers should be inspected for cracks, loose caps, or visible moisture, and labels should record identity, lot, and receipt date. Lyophilized material is often allowed to equilibrate to room temperature before opening to prevent condensation on the powder. Gloves and a clean workspace reduce contamination and static-related loss. Once opened, the vial may be purged with inert gas and resealed if the peptide is sensitive to oxygen or humidity. These steps are procedural safeguards rather than guarantees of stability.
Reconstitution introduces new risks because the peptide contacts solvent, air, and container surfaces. The chosen solvent should match the peptide's solubility profile, and buffer salts, pH, and ionic strength can affect dissolution and subsequent stability. Gentle mixing is preferred over vigorous vortexing, which can create interfaces and shear. If the solution is not clear, the cause may be incomplete dissolution, aggregation, or insoluble counter-ions rather than a simple concentration problem. Filtration is sometimes used, but filters can adsorb peptides and alter measured concentration.
Peptides are short amino acid polymers whose stability depends on sequence, length, and chemical modifications. In dry form, most peptides are relatively stable because low water activity slows hydrolysis and other degradation. Residual moisture, oxygen, and light can still promote oxidation, deamidation, or aggregation over time. Storage recommendations therefore usually combine low temperature, desiccation, and protection from light. Because each peptide has distinct properties, no single condition fits every sequence.
Temperature selection balances degradation rate against physical changes. Many lyophilized peptides are stored at -20 °C, while some modified or longer sequences require -80 °C for extended periods. Aqueous stock solutions are less stable and are often kept at -20 °C or below in single-use aliquots. Repeated freeze-thaw cycles can cause aggregation, precipitation, or loss of activity, so aliquoting before freezing reduces that risk. Frost-free freezers cycle above freezing and may be unsuitable for long-term peptide storage.
Container and environment choices matter. Peptides may adsorb to glass, plastic, or filter membranes, especially at low concentrations. Low-binding tubes and inert containers reduce loss. Moisture barriers include sealed bags with desiccant, and light protection uses amber vials or opaque wraps. Inert gas blankets can limit oxidation for sequences containing methionine, cysteine, or tryptophan. Buffers and pH also affect solution stability; extremes of pH accelerate hydrolysis and deamidation. These practices apply to research and manufacturing settings, not to any specific clinical use.
Aliquoting reduces repeated temperature cycling for solutions and reconstituted samples. If a peptide is supplied as a powder, reconstitution usually involves adding a suitable solvent gently along the vial wall. Mixing by inversion or slow swirling is preferred over vortexing, which can create air-liquid interfaces that promote aggregation or foaming. The resulting solution should be inspected for clarity, particles, and color before storage. Labels on aliquots typically include concentration, solvent, date, and lot number, and open questions remain about the best solvent for every sequence.
Quality control relies on analytical methods that detect changes in purity, identity, and concentration. Reverse-phase high-performance liquid chromatography separates the parent peptide from degradation products, while mass spectrometry confirms molecular mass. Water content can be measured by Karl Fischer titration, and amino acid analysis or peptide mapping may reveal sequence-level modifications. Stability studies compare stored samples against baseline material at defined intervals. Documentation should link each result to a lot number, storage condition, and test date so that trends can be reviewed.
GliZ: transcription factor that regulates expression of gli gene cluster GliP: non-ribosomal peptide synthetase that facilitates formation of cyclo-phenylalanyl-serine intermediate from serine and phenylalanine residues GliC: cytochrome P450 monooxygenase that adds hydroxyl group to the alpha carbon of the phenylalanine residue in the cyclo-phenylalanyl-serine intermediate GliG: glutathione S-transferase (GST) that adds two glutathione molecules forming a bis-glutathionylated intermediate GliK: gamma-glutamyl transferase that removes gamma-glutamyl moieties from glutathione additions GliJ: Cys-Gly carboxypeptidase that removes carboxyl moieties from glutathione additions GliI: aminotransferase that removes amino moieties from glutathione additions GliF: cytochrome P450 monooxygenase that adds hydroxyl group to the benzene residue and facilitates ring closure GliN/GliM: N-methyltransferase/O-methyltransferase that adds a methyl group to nitrogen to form the dithiol gliotoxin intermediate utilizing s-adenosyl methionine (SAM) in the reaction GliT: oxidoreductase thioredoxin that mediates closure of the disulfide-bridge GliA: Major Facilitator Superfamily transporter that secretes gliotoxin across cell membrane The exact roles of the enzymes GliC, GliF, GliM, and GliN and the steps in the biosynthetic pathway of these enzymes are still not completely understood in the biosynthesis of gliotoxin. Regulation of Biosynthesis Some gliotoxin molecules are not secreted by GliA and remain in the cell.
=== Titles and styles === 9 May 1892 – 21 October 1911: Her Royal Highness Princess Zita of Parma 21 October 1911 – 28 June 1914: Her Imperial and Royal Highness Archduchess Zita, Archduchess Karl of Austria, Princess of Parma 28 June 1914 – 21 November 1916: Her Imperial and Royal Highness The Archduchess of Austria-Este 21 November 1916 – 3 April 1919: Her Imperial and Royal Apostolic Majesty The Empress of Austria, Apostolic Queen of Hungary and Croatia, Slavonia and Dalmatia
=== In plants === DAMPs in plants have been found to stimulate a fast immune response, but without the inflammation that characterizes DAMPs in mammals. Just as with mammalian DAMPs, plant DAMPs are cytosolic in nature and are released into the extracellular space following damage to the cell caused by either trauma or pathogen. The major difference in the immune systems between plants and mammals is that plants lack an adaptive immune system, so plants can not determine which pathogens have attacked them before and thus easily mediate an effective immune response to them. To make up for this lack of defense, plants use the pattern-triggered immunity (PTI) and effector-triggered immunity (ETI) pathways to combat trauma and pathogens. PTI is the first line of defense in plants and is triggered by PAMPs to initiate signaling throughout the plant that damage has occurred to a cell. Along with the PTI, DAMPs are also released in response to this damage, but as mentioned earlier they do not initiate an inflammatory response like their mammalian counterparts. The main role of DAMPs in plants is to act as mobile signals to initiate wounding responses and to promote damage repair. A large overlap occurs between the PTI pathway and DAMPs in plants, and the plant DAMPs effectively operate as PTI amplifiers. The ETI always occurs after the PTI pathway and DAMP release, and is a last resort response to the pathogen or trauma that ultimately results in programmed cell death.
"Cocaine nose" or "coke nose" are informal terms that refer to nose disorders resulting from repeated or chronic cocaine use. About 30% of people who had snorted cocaine at least 25 times but less than daily, and 47% of daily users, reported experiencing nasal irritation, crusting or scabbing, and frequent nosebleeds. Cocaine use should be considered as a potential cause of persistent or unexplained rhinitis, including in adolescent patients. Because the nose is a prominent facial feature, such visible damage often leads to embarrassment, stigma, and negative reactions from others. As a result, individuals with cocaine-induced nasal damage frequently withdraw from social activities and relationships, leading to social isolation. In many cases, this isolation is not just likely but almost inevitable, as affected individuals may feel unable to face the outside world due to the noticeable and sometimes severe changes to their appearance. Nose disorders associated with cocaine nose include:
== Products in development == As of September 2014, Eurogentec Biologics was developing a vaccine against bilharziosis called Bilhvax in partnership with INSERM and researchers from the Pasteur Institute; the vaccine candidate was starting Phase III trials at that time.
Sources: en.wikipedia.org
== References == This article was adapted from the following source under a CC BY 4.0 license (2018) (reviewer reports): Cody J Hall; Tatiana P. Soares da Costa (2018). "Lysine: biosynthesis, catabolism and roles" (PDF). WikiJournal of Science. 1 (1): 4. doi:10.15347/wjs/2018.004. Wikidata Q55120301.
== Coupling with THG microscopy == Third-Harmonic Generation (THG) microscopy can be complementary to SHG microscopy, as it is sensitive to the transverse interfaces, and to the 3rd order nonlinear susceptibility
The thus-produced 249Bk has a long half-life of 330 days and thus can capture another neutron. However, the product, 250Bk, again has a relatively short half-life of 3.212 hours and thus does not yield any heavier berkelium isotopes. It instead decays to the californium isotope 250Cf:
The 10th-century church in Rossano, together with the "twin" church of Sant'Adriano in San Demetrio Corone (foundation 955, rebuilt by the Normans on the still visible foundation of the previous Byzantine church), are considered among the country's best preserved Byzantine churches. They were built by St. Nilus the Younger as a retreat for the monks who lived in the tufa grottos underneath. The present name of Calabria comes from the duchy of Calabria. Around 800, Saracens began invading Calabria, attempting to wrest control from the Byzantines. This group of Arabs had been successful in Sicily. The people of Calabria retreated into the mountains. Although the Arabs never got a strong hold on the whole of Calabria, they did control some villages while enhancing trade relations with the eastern world. In 918, Saracens captured Reggio (which they renamed Rivà), holding many of its inhabitants to ransom or enslaving them. During this time many staples of later Calabrian cuisine came into fashion: citrus fruits and eggplants for example. Exotic spices such as cloves and nutmeg were introduced. Under Byzantine rule, between the end of the 9th and the beginning of the 10th century, Calabria was one of Italy's first regions to introduce silk production. Mulberry trees for the production of raw silk were introduced to southern Italy by the Byzantines at the end of the ninth century. Around 1050 Calabria had 24,000 mulberry trees cultivated for their foliage. At the beginning of the 10th century (c.
Sources: en.wikipedia.org
== Military career == After graduating from the Military Academy, al-Burhan worked in Khartoum, as part of the Sudanese army, and participated in the fighting fronts in the Darfur war and in the Second Sudanese Civil War in South Sudan and other regions. He was regional commander in Darfur. He later traveled to Egypt and then to Jordan to receive training courses in his military field until in 2018 he was appointed commander of the ground forces of the army. Al-Burhan held several positions throughout his career as he began as a soldier with the Border Guard Forces and later became commander of this force before becoming Deputy Chief of Staff of the Ground Forces Operations and then Chief of Staff of the Sudanese Army in February 2018 before he served as Inspector General of the Army for a period of time. By 26 February 2019, during the massive protests that swept the country and demanded the fall of Omar al-Bashir's regime, al-Burhan was elevated to the rank of lieutenant general.
=== 1849–1950: Early history === Pfizer was founded in 1849 as Charles Pfizer & Company by Charles Pfizer and Charles F. Erhart, two cousins who had immigrated to the United States from Ludwigsburg, Germany. The business produced chemical compounds, and was headquartered on Bartlett Street in Williamsburg, Brooklyn, where it produced an antiparasitic called santonin. This was an immediate success, although it was production of citric acid that led to Pfizer's growth in the 1880s. Pfizer continued to buy property in the area (by now the Williamsburg district of the city of Brooklyn, New York and beginning in 1898, the City of Greater New York) to expand its lab and factory, retaining offices on Flushing Avenue until the 1960s; the Brooklyn plant ultimately closed in 2009. Following its success with citric acid, Pfizer (at the now-demolished 295 Washington Avenue) and Erhart (at 280 Washington Avenue) established their main residences in the nearby Clinton Hill district, known for its concentration of Gilded Age wealth. In 1881, Pfizer moved its administrative headquarters to 81 Maiden Lane in Manhattan, presaging the company's expansion to Chicago, Illinois, a year later. By 1906 sales exceeded $3 million. World War I caused a shortage of calcium citrate. Pfizer imported the compound from Italy for the manufacture of citric acid, and due to the disruption in supply, the company began a search for an alternative. They found this in the form of a fungus capable of fermenting sugar to citric acid.
Antibiotics for bacterial infections. Antivirals for viral infections. Antifungals for fungal infections. Antiprotozoals for protozoan infections. Antihelminthics for infections caused by parasitic worms. Infectious diseases remain a significant global health concern; communicable, maternal, neonatal, and nutritional diseases together accounted for an estimated 18.6% of global deaths in 2017. The branch of medicine that focuses on infections is referred to as infectious diseases.
Sources: en.wikipedia.org
Lyophilized peptides have low water activity, which slows hydrolysis and many oxidative pathways. Low temperatures further reduce residual chemical reactivity and microbial growth risk. The exact temperature depends on peptide stability data and expected storage duration.
Common pathways include hydrolysis, oxidation, deamidation, and aggregation. Their rates depend on pH, moisture, oxygen, trace metals, light, and temperature. Container surfaces and air-liquid interfaces can also promote loss or structural change.
No. Freezing can concentrate salts and buffer species, cause pH shifts, and damage peptides during ice crystal formation. Repeated freeze-thaw cycles are particularly disruptive. Refrigeration or single-use aliquots may be preferable for some solutions.
Common solvents include sterile water, phosphate-buffered saline, and water-acetonitrile mixtures. The choice depends on the peptide's solubility profile and the buffer compatibility for the intended application. Manufacturers often provide a recommended solvent on the product information sheet.